In the BioHarmony Drug Report Database

"Preview" Icon

Ipilimumab

Yervoy (ipilimumab) is an antibody pharmaceutical. Ipilimumab was first approved as Yervoy on 2011-03-25. It is used to treat melanoma in the USA. It has been approved in Europe to treat colorectal neoplasms, malignant mesothelioma, melanoma, non-small-cell lung carcinoma, and renal cell carcinoma. The pharmaceutical is active against cytotoxic T-lymphocyte protein 4.

 

Trade Name

 

Yervoy
 

Common Name

 

ipilimumab
 

ChEMBL ID

 

CHEMBL1789844
 

Indication

 

colorectal neoplasms, malignant mesothelioma, melanoma, non-small-cell lung carcinoma, renal cell carcinoma
 

Drug Class

 

Monoclonal antibodies

Image (chem structure or protein)

Ipilimumab structure rendering